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Fluorescence resonance energy transfer (FRET) is a powerful method for the
detection and quantification of stationary and dynamic protein-protein interactions.
Technical limitations have hampered systematic in vivo FRET experiments to study
protein-protein interactions in their native environment. Here, we describe a rapid and
robust protocol that combines adeno-associated virus (AAV) vector-mediated in vivo
delivery of genetically encoded FRET partners with ex vivo FRET measurements. The
method was established on acutely isolated outer segments of murine rod and cone
photoreceptors and relies on the high co-transduction efficiency of retinal photoreceptors
by co-delivered AAV vectors. The procedure can be used for the systematic analysis of
protein-protein interactions of wild type or mutant outer segment proteins in their native
environment. Conclusively, our protocol can help to characterize the physiological and
pathophysiological relevance of photoreceptor specific proteins and, in principle, should
also be transferable to other cell types.
Keywords: fluorescence resonance energy transfer, FRET, adeno-associated viral vectors, AAV, protein-protein
interaction, photoreceptor, outer segment
INTRODUCTION
The outer segments (OS) of rod and cone photoreceptors are highly specialized cilia harboring all
proteins involved in light-induced phototransduction (Arshavsky and Burns, 2012). Mutations in
genes encoding these proteins lead to untreatable diseases that severely impair rod and/or cone
structure and/or functionality (Berger et al., 2010). The majority of these genes encode proteins
that are organized in large macromolecular complexes assembled by networks of homomeric
and/or heteromeric protein-protein interactions (Roepman and Wolfrum, 2007). To decipher
pathomechanisms underlying the retinal disorders and to develop appropriate treatments, the
identification and characterization of these networks is inevitable. So far, the vast majority of OS
protein-protein interaction studies in photoreceptors were performed using classical biochemical
techniques (Goldberg et al., 1995; Loewen and Molday, 2000; Poetsch et al., 2001; Jastrzebska et al.,
2004; Michalakis et al., 2011; Knepp et al., 2012). However, the biochemical techniques have several
limitations: (i) They strongly rely on the availability of antibodies with high affinity and specificity,
(ii) they do not necessarily reflect “true” interactions since, due to the tissue homogenization, some
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proteins may randomly interact even though they are spatially
separated in vivo, (iii) they do not allow for dynamic
measurements, and (iv) exact quantification of interactions is
rather difficult as many different technical parameters which
might influence the interaction must be controlled rigorously.
With regard to these obstacles, FRET is superior to the
biochemical approaches. One important constraint of FRET is
the fact that it requires the co-expression of the fluorescently
tagged molecules in a given cell type. This can be easily
handled in heterologous expression systems, however, in complex
organisms like mammals the application of FRET has been
hampered by the laborious and time consuming generation of
transgenic animals. Therefore, only a few FRET-based studies
were performed in vivo, most of them using FRET biosensors for
analysis of spatiotemporal dynamics of small signaling molecules
(Hovan et al., 2010; Hirata et al., 2012; Wen et al., 2013;
Kumagai et al., 2014). Here, we describe a protocol for systematic
monitoring of protein-protein interactions without the necessity
of generating transgenic animals. The technique utilizes adeno-
associated virus (AAV) vectors that are valuable tools for in vivo
gene transfer into brain and retinal neurons (Schön et al.,
2013; Murlidharan et al., 2014; Trapani et al., 2014; Zacchigna
et al., 2014). AAVs lead to long-term ectopic expression of the
transgene in mammals and thus can be used as a rapid alternative
to the generation of transgenic animals. We have already used
AAV mediated viral gene expression in retinal neurons in our
previous studies (Becirovic et al., 2014, 2016; Nguyen et al.,
2016).
The protocol allows for rapid and robust measurements
of sensitized acceptor emission FRET on isolated virally
transduced murine photoreceptor OS. The complete procedure
can be performed within 3 weeks on wild type animals
and requires only limited expertise and special equipment
(Figure 1). We show that this method is suitable for the
detection and quantification of protein-protein interactions of
proteins involved in the pathogenesis of hereditary degenerative
retinal diseases. We propose the application of this method for
FRET-based protein-protein interaction studies in other primary
cilia of many cell types to study the pathogenesis of other
ciliopathies.
Experimental Procedure
The genes of interest encoding each of the protein-protein
interaction partners are C- and/or N-terminally fused to
the genes encoding citrine or cerulean, two FRET-optimized
derivatives of YFP and CFP, respectively (Griesbeck et al.,
2001; Rizzo et al., 2004). Each of these constructs is then
cloned into the multiple cloning site of a rAAV cis-plasmid
containing the rod photoreceptor specific human rhodopsin
(hRHO) (Allocca et al., 2007) or murine short wavelength opsin
(mSWS) promoter (Michalakis et al., 2010a), a Woodchuck
hepatitis virus posttranscriptional regulatory element (WPRE),
and a bovine growth hormone polyadenylation signal (BGH
pA). Subsequently, each rAAV cis plasmid is co-transfected
with the trans (AAV helper and Adeno helper) plasmids
into HEK293T cells using triple Ca2+ phosphate transfection.
rAAV particles are then purified in a multistep procedure
that yields high titers of approx. 1013 vector genomes (vg)
per ml. For FRET measurements, 1 × 109 total vg of each
construct is delivered into the subretinal space of anesthetized
mice. For co-transduction experiments of two titer-matched
constructs a total number of 2 × 109 total vg is injected.
The co-transduction efficiency was up to 90% in rods and
up to 30% in cones after co-delivery of mixtures of two
rAAVs. The isolation of rod or cone OS was performed
10–14 days post-injection using a modified version of the
mechanical share method (Mitchell et al., 2009). Three cube
FRET measurements were carried out using a slightly modified
version of the protocol described previously (Erickson et al.,
2003; Shaltiel et al., 2012; Ben Johny et al., 2013). The isolated
OS were stable for several hours after isolation, which in
principle also allows for dynamic FRET measurements of single
interactions.
Using this method, we were able to confirm several
homomeric and heteromeric protein-protein interactions in rod
OS that had been previously observed using other (biochemical)
methods. In addition, we also identified novel protein-protein
interactions in OS of rods and cones. Furthermore, we
demonstrate that FRET is applicable to quantify the effects
of disease associated point mutations on protein-protein
interactions in these compartments. Conclusively, we show that
our FRET protocol enables robust qualitative and quantitative
measurements of protein-protein interactions in small cellular
compartments like photoreceptor OS.
Advantages of the Method
Compared to FRET and other ex vivo measurements of protein-
protein interactions, which are currently widely used, this
method has several advantages:
(i) It can be performed within 3 weeks including the
production of specific rAAVs. The isolation of OS can be
carried out within a few minutes and yields a high quantity
of OS of adequate quality and purity.
(ii) It allows for systematic analysis of protein-protein
interactions ex vivo in a specialized small compartment
with preserved native morphology.
(iii) It is principally transferable to analyses of protein-protein
interactions in ciliary compartments of other tissues (e.g.,
respiratory cilia and olfactory cilia). This is of special
importance for deciphering the disease mechanisms of a
large group of diseases known as ciliopathies.
(iv) As isolated OS are stable for up to 6 h, the method can also
be used for dynamic FRET measurements.
(v) The protocol was established in wild type mice. Thus, it
allows for systematic analysis of disease mechanisms of
single disease associated point mutations without the time
consuming generation of transgenic animals.
(vi) It can in principle be used to determine the relative binding
affinities of single interactions.
(vii) The co-transduction efficiency for two constructs was up
to 90% for rod OS and up to 30% for cone OS. Hence,
a sufficient number of OS co-expressing both proteins of
interest can be isolated from a single animal.
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FIGURE 1 | Schematic overview of the main steps of the procedure. AAV vectors encoding the FRET fusion proteins are produced in HEK293T cells (day 1–10).
Single AAV vectors and combinations of AAVs encoding the FRET partners are delivered into the subretinal space of wildtype mice (day 11). Ten days later, OS are
isolated for ex vivo FRET measurements.
(viii) In principle, it can be adapted for the establishment of
FRET measurements on retinas of living animals.
(ix) Due to its easy handling our protocol should also be
transferable to other tissues or organisms.
Limitations of the Method
There are a few limitations of themethod, which can be overcome
by appropriate techniques or conditions:
(i) With respect to the packaging capacity of rAAVs (5 kb)
(Trapani et al., 2014), this method seems less suitable for
analysis of protein-protein interactions of large proteins.
However, there are several approaches showing that larger
transcripts can also be packaged into rAAVs, even though
with lower efficiencies (Trapani et al., 2014).
(ii) The endogenous wild type proteins in the OS of transduced
photoreceptors interfere with the labeled constructs and
lead to overall lower FRET efficiencies than expected
from in vitro experiments (incomplete labeling) (Becirovic
et al., 2014). This limitation should be of relevance only
if weak interactions are expected. This issue could be
overcome by using appropriate single or double knock-
out animals, which lack expression of the endogenous
(unlabeled) proteins of interest.
(iii) So far, we found no short or long term toxic effects
of the fluorophores on the structural integrity of the
retina, which is consistent with previous studies (Bennett
et al., 1999; Becirovic et al., 2014). However, we cannot
exclude that large amounts of specific cerulean- or
citrine-tagged proteins could have toxic effects that
influence photoreceptor function and morphology.
Therefore, to exclude any toxic effects, we suggest using
histological analysis of retinal cross sections prior to the
actual FRET measurements for each construct.
(iv) In the case of three cube FRET, in addition to the
simultaneous delivery of two FRET partners, injections of
single FRET constructs are also necessary. They serve as
bleed-through and crosstalk controls for the determination
of the FRET efficiencies.
(v) Overexpression of the tagged proteins by strong promoters
might result in an artefactual FRET signal. To exclude
this possibility, additional controls might be necessary.
In this context, the most eligible control is to use point
mutations within the protein-protein interaction site of one
(or both) FRET partners. If the protein interaction interface
is not known, artefactual FRET signal can be excluded by
overexpressing other proteins not expected to interact with
the respective FRET partner.
(vi) Bulky fluorescent tags could possibly hinder proper
trafficking or localization of the fusion protein (Feilmeier
et al., 2000). In addition, they might influence the proper
folding and the stability of the protein. In turn, incorrect
folding may also affect the fluorophore itself and lead
to little or no fluorescence (Waldo et al., 1999). If
these problems occur, they can be overcome by varying
the position of the fluorescent tag within the protein
or by placing a short linker sequence between tag and
protein.
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MATERIALS AND EQUIPMENT
Animals
All procedures were performed on P14-21 C57BL/6J mice
with permission from local authorities (District Government
of Upper Bavaria). Anesthesia was performed by subcutaneous
injection of ketamine (40mg/kg body weight) and xylazine
(20mg/kg body weight). Euthanasia was performed by cervical
dislocation.
Reagents
• Sodium chloride (NaCl; VWR, cat. no. 27810.364)
• Potassium chloride (KCl; Carl Roth, cat. no. 6781.1)
• Magnesium chloride hexahydrate (MgCl2 × 6H2O; Carl Roth,
cat. no. 2189.1)
• Calcium chloride dihydrate (CaCl2 × 2H2O; VWR, cat. no.
22317.230)
• Glucose monohydrate (Carl Roth, cat. no. 6887.1)
• HEPES sodium salt (VWR, cat. no. A16516.22)
• Sodium hydroxide, 5M (NaOH; VWR, 28244.295)
• KAPA SYBR FAST Universal x2 qPCRMasterMix (peqlab, cat.
no. 07-KK4600-01)
• Poly-L-lysine, 1mg/ml (Sigma, cat. no. P2636)
• Polybrene/Hexadimethrine bromide (Sigma, cat. no. 107689)
• Dextran (Sigma, cat. no. 95771)
• BES sodium salt (Sigma, cat. no. B2891)
• AAV cis (for cloning of the expression cassette) and trans
plasmids (encoding for Cap, Rep and adenoviral helper genes)
can be obtained from various sources including Penn Vector
Core (http://www.med.upenn.edu/gtp/vectorcore) or from
UNC Vector Core (http://www.med.unc.edu/genetherapy/
vectorcore,seealsoRef. Grieger et al., 2006)
• Benzonase (VWR, cat. no. 1.01695.0001)
• OptiPrep (Progen, cat. no. 1114542)
• Disodium hydrogen phosphate (Na2HPO4; Sigma, cat. no.
S9763)
• Sodium dihydrogen phosphate (NaH2PO4; Sigma, cat. no.
S5011)
• Tris(hydroxymethyl)aminomethane (TRIS; VWR, cat. no.
71003-490)
• Phenol red (Sigma, cat. no. P3532)
• Tween 20 (Sigma, cat. no. P2287).
Equipment for rAAV Preparation and
Subretinal Injection
• Vortexer
• Microcentrifuge tubes, 1.5ml
• Microcentrifuge tubes with screw cap, 1.5ml
• ibidi µ-dish, 35mm, low (ibidi, cat. no. 80131)
• Room temperature bench top centrifuge (1.5ml tube rotor)
• Petri dishes, 3 cm
• Forceps
• Polystyrene tubes, 50ml
• Cell culture dishes, 15 cm
• Cell scraper (VWR, cat. no. 734-1111)
• Liquid nitrogen
• Quick-Seal polypropylene tubes, 39ml (Beckman, cat. no.
342141)
• Glass pipettes
• Peristaltic pump MINIPULS 3 (Gilson, cat. no. n/a)
• Quick-Seal Cordless Tube Topper kit, 50Hz (Beckman, cat.
no. 358313)
• Beckman Coulter J2-MC high speed centrifuge (Beckman, cat.
no. n/a)
• JA-10 Rotor, Fixed Angle, Aluminum, 6× 500ml, 10,000 rpm,
17,700× g (Beckman, cat. no. 369687)
• Beckman Coulter Optima LE-80K ultracentrifuge (Beckman,
cat. no. n/a)
• 70 Ti Rotor, Fixed Angle, Titanium, 8 × 39mm, 70,000 rpm,
504,000× g (Beckman, cat. no. 337922)
• Syringe needle, 21-gauge
• Syringe, 5ml
• Sterile syringe filters with acrylic housing, 0.2µm, cellulose
acetate (VWR, cat. no. 28145-477)
• HiTrap Q FF sepharose column, 5ml (GE Healthcare, cat. no.
17-5156-01)
• Superloop, 50ml (GE Healthcare, cat. no. 19-7850-01)
• ÄKTAprime plus chromatography system (GEHealthcare, cat.
no. 11-0013-13)
• PrimeView 5.31 software (GE Healthcare, cat. no. 28-9949-61)
• Amicon Ultra-4 centrifugal filter units, 100 kDa (Millipore,
cat. no. UFC810024)
• LightCycler 480 multiwell plate 96 (Roche, cat. no.
04729692001)
• LightCycler 480 Sealing Foil (Roche, cat. no. 04729757001)
• LightCycler 480 Instrument II real-time PCR amplification
and detection instrument (Roche, cat. no. 05015278001)
• NanoFil syringe, 10µl (World Precision Instruments, cat. no.
NANOFIL)
• NanoFil 34-gauge beveled needle (World Precision
Instruments, cat. no. NF34BV-2)
• Nanodrop 2000c UV-Vis spectrophotometer (peqlab, ca. no.
91-ND-2000C)
• Dexpanthenol eye and nose salve, 5% (Bepanthen, Bayer Vital
GmbH, cat. no. 1578681)
• OPMI 1 FR pro surgical microscope (Zeiss, cat. no. n/a)
• Gentamicin 5 mg/g and dexamethasone 0.3 mg/g eye
salve (Dexamytrex, Dr. Gerhard Mann GmbH, cat. no.
2747789)
• Dissection stereomicroscope Stemi 2000 (Zeiss, cat. no.
495005-0022-000)
• Epifluorescence microscope Axioplan 2 imaging (Zeiss, cat.
no. n/a).
Equipment for Three Cube FRET
Measurements
• Inverted fluorescent microscope (Leica, cat. no. DMI6000B)
• HC PL APO 63x/1.40-0.60 oil immersion objective (Leica, cat.
no. 11506349)
• Cerulean filter cube, excitation: ET436/20x, Dichroic: T455lp,
emission: ET480/40m, transmission rate 93–97% (Chroma
Technology, cat. no. 49001)
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• Citrine filter cube, excitation: ET500/20x, Dichroic: T515lp,
emission: ET535/30m, transmission rate 93–97% (Chroma
Technology, cat. no. 49003)
• FRET filter cube, excitation: ET436/20x, Dichroic: T455lp,
emission: ET535/30m, transmission rate 93–97% (Chroma
Technology, cat. no. 49052)
• DeltaRamX monochromator (Horiba, cat. no. n/a)
• D-104 B microscope photometer (Horiba, cat. no. n/a)
• Xenon short arc lamp type UXL-75XE (Ushio Inc. Japan, cat.
no. n/a)
• PMT housing 914 (Horiba, cat. no. n/a)
• R1527 photomultiplier (Horiba, cat. no. n/a)
• FelixGX software (Horiba, cat. no. n/a)
• MATLAB R© R2014b (MathWorks. Inc., cat. no. n/a)
• Excel software (Microsoft Corporation, cat. no. n/a).
Buffers and Solutions
2x BBS transfection solution Final component concentrations
are 45mMBES, 280mMNaCl, 1.5mMNa2HPO4. Adjust the pH
to 6.95 and sterile filtrate. Prepare 50ml aliquots and store them
at 4◦C for up to 1 year.
Lysis Buffer Final component concentrations are 150mM
NaCl, 50mM TRIS. Adjust the pH to 8.5 and sterile filtrate.
Prepare freshly before use.
15% iodixanol solution Final component concentrations are
1x PBS (phosphate buffered saline), 1mM MgCl2, 2.5mM KCl,
1M NaCl, 15% Optiprep. Add phenol red (use 1% solution) ad
libitum until the solution is visibly colored. Store at 4◦C for up to
1 week.
25% iodixanol solution Final component concentrations are
1x PBS, 1mM MgCl2, 2.5mM KCl, 25% Optiprep. Add phenol
red (use 1% solution) ad libitum until the solution is visibly
colored. Store at 4◦C for up to 1 week.
40% iodixanol solution Final component concentrations are
1x PBS, 1mMMgCl2, 2.5mMKCl, 1MNaCl, 40%Optiprep. The
solution remains uncolored. Store at 4◦C for up to 1 week.
60% iodixanol solution Final component concentrations are
1mM MgCl2, 2.5mM KCl, 60% Optiprep. Add phenol red (use
1% solution) ad libitum until the solution is visibly colored. Store
at 4◦C for up to 1 week.
PBS-MK solution Final component concentrations are 1x
PBS, 1mM MgCl2, 2.5mM KCl. Sterile filtrate and store at 4◦C
for up to 1 week.
Buffer A Final component concentrations are 20mM TRIS,
15mMNaCl. Adjust the pH to 8.5. Store at 4◦C for up to 1 week.
Buffer B Final component concentration is 2.5M NaCl.
Adjust the pH to 8.5. Store at 4◦C for up to 1 week.
FRET imaging solution Final component concentrations are
140mM NaCl, 5mM KCl,
1mM MgCl2, 2mM CaCl2, 10mM glucose, 10mM HEPES
sodium salt. Adjust the pH with 5M NaOH to 7.4. Prepare 50ml
aliquots and store them at −20◦C for up to 1 year. Store thawed
aliquots at 4◦C for up to 1 week.
FRET Imaging Setup
Imaging dishes We recommend the use of commercially
available glass-bottomed cell-culture dishes for imaging. They
should be coated with Poly-L-lysine to ensure complete
adherence and immobilization of OS. In our hands, the use of
pre-coated dishes (e.g., ibiTreat, ibidi) resulted in insufficient OS
adherence.
Inverted epifluorescent microscope, excitation source, and
detection All measurements were performed using a Leica
DMI6000B inverted fluorescent microscope equipped with a
motorized turret and a 63x oil objective. Themicroscope contains
a motorized filter-wheel enabling rapid switching of filter cubes
within 300ms. Of note, the 40x oil objective is also suitable for
FRET measurements on isolated OS. The fluorescent intensity
is detected by a photomultiplier detection system including a
photomultiplier tube (Horiba). As excitation source, we use
a DeltaRam monochromator containing a 150W xenon high
stability lamp. The use of a conventional LED lamp is also
suitable. However, it is crucial to achieve a stable uniform
illumination.
Excitation filter, emission filter, and dichroic mirror
The following filter cubes are present in our microscope: A
donor cube containing a cerulean excitation filter, T455lp
dichroic mirror and a cerulean emission filter; an acceptor
cube with a citrine excitation filter, T515lp dichroic mirror,
and a citrine emission filter. Furthermore a FRET cube
containing a cerulean excitation filter, T455lp dichroic
mirror and a citrine emission filter. In case of using a
monochromator as excitation source, the excitation filters are
optional.
Software and data acquisition For photometric FRET
measurements, we employ the three cube FRET method
(Erickson et al., 2003; Shaltiel et al., 2012; Ben Johny et al.,
2013) that utilizes the detection of fluorescence intensities
from a specimen using three filter cubes. The excitation
source (DeltaRam monochromator) and appendant excitation
parameters (e.g., wavelength, pulse duration) are thereby
controlled via the software FelixGX, whereas the filter switch
is done manually. Fluorescence intensity signals are acquired
with the FelixGX software and deciphered with a custom-written
MATLAB script. Subsequent analysis is performed using Excel or
an adequate data processing software.
STEPWISE PROCEDURES
Production and Titer Determination of
rAAVs
Transfection, Harvesting, and Lysis of HEK293T Cells
The production and handling of recombinant pseudotyped
AAV2-derived vectors is subject to biosafety level 1. For a detailed
protocol on AAV production, see ref. (Grieger et al., 2006). 24 h
before transfection, confluent 15-cm-dishes of HEK293T cells
were split into 15 15-cm-dishes for each construct. For calcium
phosphate transfection, the components listed in Table 1 (the
amounts are adjusted for transfection of 15 15-cm-dishes) were
added in a 50-ml polystyrene tube. The following two equations
are used to calculate the amount of pAd Helper plasmid and
AAV2/8 Cap/Rep plasmid needed for the pre-transfection mix
described in Table 1, respectively:
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x (amount of pAd Helper) =
m (transgene AAV) × MM (pAd Helper)
MM (transgene AAV)
=
270 µg × 9509 g
mol
MM (transgene AAV)
y
(
amount of AAV 2/8 Rep/Cap
)
=
m
(
transgene AAV
)
×MM
(
AAV 2/8 Rep/Cap
)
MM
(
transgene AAV
) = 270 µg × 4523
g
mol
MM
(
transgene AAV
)
MM =molar mass of double stranded plasmid.
While vortexing the pre-transfection mix in the polystyrene
tube at maximum speed, 15ml 2x BBS was added dropwise. The
mixture was incubated at room temperature for 4–5min and
2ml of the transfection mix was added dropwise to each 15-
cm-dish of ∼80% confluent HEK293T cells. Transfected cells
were then incubated at 37◦C and 5% CO2 atmosphere for 24 h.
Subsequently, the medium from transfected cells was replaced
and the cells were incubated at 37◦C and 10% CO2 atmosphere
for additional 24 h. 48 h post transfection, the cells were harvested
by scraping them from each 15-cm-dish. Cell suspensions were
collected from 15 dishes in a 500-ml-centrifuge-tube. The cells
were centrifuged at 2000 × g for 15min at 4◦C (4000 rpm
in a J2-MC Beckman centrifuge using a JA-10 rotor). After
medium removal, the cell pellet was gently resuspended in
7.5ml lysis buffer (volume for cell pellet harvested from 15
15-cm-dishes) and transferred into 50-ml-polystyrene-tubes.
The cell suspension was shock-freezed in liquid nitrogen and
subsequently thawed at 37◦C. Freeze-thaw cycle was repeated two
additional times. The resulting cell suspension can be stored at
−80◦C overnight.
Gradient Centrifugation and Purification of rAAVs
Benzonase was added to the thawed cell suspension to a final
concentration of 50 U/ml followed by an incubation at 37◦C for
30min. Subsequently, the cells were pelleted via centrifugation
at 2000 × g for 25min at 4◦C. The virus-containing supernatant
was transferred into a Beckman Quick-Seal polypropylene tube.
To form the iodixanol gradient, a sterile, long glass pipette,
and a Gilson MINIPULS3 pump were used. First, the virus-
containing phase was underlaid with 7ml 15% iodixanol, then
with 5ml 25% iodixanol, followed by 5ml 40% iodixanol, and at
last with 6ml 60% iodixanol. To avoid mixing of the layers, the
pump should be run at the slowest speed. Polypropylene tubes
TABLE 1 | Reagents for a pre-transfection mix of one transgene AAV
construct.
Reagent Amount
Transgene AAV cis plasmid (Michalakis et al., 2010b;
Koch et al., 2012)
270µg
pAd Helper plasmid (pAdDeltaF6 Auricchio et al., 2001) x µg
AAV2/5 (Hildinger et al., 2001) or AAV2/8 (Gao et al.,
2002) Rep/Cap plasmid
y µg
Polybrene (8mg/ml) 15µl
Dextran (10mg/ml) 1500µl
2.5M CaCl2 1500µl
Double-distilled water ad 15ml
The listed amounts are for transfection of 15 15-cm-dishes of HEK293T cells.
were filled up and accurately balanced with PBS-MK. Prior to
centrifugation, the tubes were sealed with the Beckman Tube
Topper. Centrifugation was performed at 361.000 × g for 1 h
45min at 18◦C (70.000 rpm in an Optima LE-80K Beckman
ultracentrifuge using a 70 Ti rotor). During centrifugation, the
virus-containing fraction should accumulate in the 40% phase.
After centrifugation, the tube was pierced at the top near the
seal for pressurization. To collect the virus-containing phase, a
21-gauge-needle was used with a 5-ml-syringe to pierce the tube
through the side at the lower end of the 40–60% interface. During
this step, the open site of the needle tip should face the 40% phase.
Approximately 5ml of the 40% phase were collected. The virus-
containing phase can be stored in a 15-ml-polystyrene-tube at
−80◦C until proceeding with the purification step.
For purification, the virus-containing phase was thawed
on ice. HiTrap Q FF sepharose column and superloop were
connected with the ÄKTAprime plus chromatography system.
For collection of the purified fractions, 1.5-ml-centrifuge-tubes
were loaded into the tube rack. Dropsync unit was adjusted to
position 1. The HiTrap Q FF sepharose column was equilibrated
with 25ml of buffer A at 10ml/min flow rate. Manual run mode
was selected with 1.0ml/min flow rate, 1ml fraction size, and the
measuring curves were put to starting point via autozero. Virus
phase was diluted 1:1 with buffer A prior to application to the
ÄKTAprime plus systemwith a 10ml syringe to fill the superloop.
The virus dilution from the superloop was injected into the
ÄKTAprime plus system and 1ml fractions were collected in
1.5-ml-tubes. During this step, the UV and conductance curves
should be monitored via the Äktaprime software. When the
conductance curve has reached basal values, the ÄKTAprime plus
system was switched to 100% buffer B at 10ml/min flow rate
and 0ml fraction size to purge the sepharose column from the
remaining virus dilution. To wash out the remaining salt from
the system, sterile, double-distilled water was used at 10ml/min
flow rate.When the conductance curve reached zero, the washing
step was continued for additional 5min. All of the collected 1-ml
fractions within the plateau phase of the conductance curve were
pooled. The purified and pooled virus fractions can be stored in a
15-ml-polystyrene-tube at−80◦C until continuing with the virus
concentration step.
Concentration of rAAVs
For virus concentration, the purified virus fraction was first
thawed on ice. 4ml of the fraction was then transferred to an
Amicon centrifugal filter unit and was centrifuged at 2000 × g
for 10min at 20◦C (4000 rpm in a Beckman centrifuge using a
JA-10 rotor). The flow-through was discarded and the cycles of
4ml virus fraction transfer and subsequent centrifugation were
repeated until the complete virus was loaded to the column and
∼500µl remained in the filter unit. The concentrated virus was
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washed with 1ml 0.014% Tween/PBS-MK by pipetting up and
down five times. The virus suspension was then centrifuged at
2000 × g at 20◦C until 100µl of concentrated virus suspension
remained in the filter unit. The supernatant was aliquoted and
stored in 1.5-ml screw cap tubes. Virus suspensions were stored at
−80◦C until determination of virus titer and subretinal injection.
Titer Determination of rAAVs
For titer determination, the virus suspension was diluted
1:500 with double-distilled water. 5µl of virus dilution, a
standard sample, and double-distilled water were used for
quantitative real-time PCR according toTables 2, 3. For standard
preparation, a small fragment within the WPRE (woodchuck
hepatitis virus posttranscriptional regulatory element) of the
pAAV2.1 vector was amplified via PCR. The corresponding
primers are listed in Table 4. The PCR product was purified after
gel electrophoresis and DNA concentration was determined with
a spectrophotometer (Nanodrop 2000c). The concentration of
the standard for 1010 copies per 5µl was calculated according to
the following equation:
c
(
pg
µl
)
=
1010 × 660× 1012 pg
mol
× fragment size
6.022× 1023 1
mol
× 5µl
c is the concentration of the standard for 1010 copies per 5µl;
660 × 1012 pg/mol is the mean molar mass of a base
pair (deoxyribosyladenosine with deoxyribosylthymidine or
deoxyribosylcytidine with deoxyribosylguanosine);
6.022× 1023/mol is the Avogadro constant;
The size of the amplified WPRE fragment is given in base
pairs.
A 10-fold serial dilution was made to obtain standards
at different concentrations. 5µl of a standard were used
to determine the virus titer via quantitative real-time PCR.
Standards were stored at−20◦C until use.
Subretinal Injection of rAAV Vectors
The procedure of subretinal rAAV injection was carried out as
described by (Mühlfriedel et al., 2013) with slight modifications.
The NanoFil 34-gauge beveled needle was sterilized before each
experiment. The 10-µl NanoFil syringe was preloaded with the
virus suspension under exclusion of air bubbles. The mouse was
anesthetized via intraperitoneal injection of xylazine (20mg/kg)
and ketamine (40mg/kg). Five percent dexpanthenol eye salve
was applied to the non-injected eye and the anesthetized mouse
TABLE 2 | Pipetting scheme for quantitative real-time PCR.
Reagent Volume (µl)
Template plasmid (50–100 ng)/standard/double-distilled water
(negative control)
5,0
KAPA SYBR FAST Universal x2 qPCR MasterMix 10,0
WPREqF (10 pmol/µl) 1,0
WPREqR (10 pmol/µl) 1,0
Double-distilled water ad 20,0
was placed on a 37◦C heating plate. The eye was dilated with
1% atropine and 0.5% tropicamide solution. The eye fundus
was focused with a stereomicroscope until blood vessels became
clearly visible. The outer layers of the eye (sclera, choroidea,
and retinal pigment epithelium) were then penetrated with the
needle in a 60◦ angle. When the needle was visible beneath the
retina, 1µl (containing approx. 109 rAAV particles) of virus
suspension was gradually applied freehand. For the co-delivery
of two constructs, a 1:1 mixture of titer matched rAAVs was
used. The formation of a clearly visible injection bleb indicated
a correct application to the subretinal space. The needle was
slowly removed from the eye, which was subsequently treated
with gentamicin 5 mg/g and dexamethasone 0.3 mg/g eye salve.
The anesthetized mouse was placed under a heat lamp and
was monitored until awaking from narcosis. If available, optical
coherence tomography (OCT) was conducted immediately after
subretinal injection to monitor the injection procedure and the
degree of subretinal detachment (Mühlfriedel et al., 2013).
Dissection of Murine Retinas and Isolation
of Photoreceptor Outer Segments
The mouse was sacrificed 10 days post injection and the injected
eye was proptosed by placing blunt forceps around the optic
nerve close to its exit from the eye. The globe was then transected
along the equator with a sharp razor blade or scalpel and the
vitreous body was removed by carefully pushing it out of the
incision with a thin needle. The forceps was pushed upwards to
detach the retina from the optic nerve and from the pigment
epithelium. The upward movement was gradually continued
until the retina lay free on the forceps. The isolated retina
was transferred into a petri dish filled with phosphate buffered
saline (PBS). The expression or co-expression of fluorescent
fusion proteins was analyzed by an epifluorescence microscope
(Axioplan 2 imaging, Zeiss). As described in Figure 2A, the retina
was transferred into a 1.5-ml-microcentrifuge-tube containing
100µl PBS. In case of weak expression or in case of isolating
cone OS, two (or more) retinas can be pooled at this stage
TABLE 3 | Program steps of quantitative real-time PCR for titer
determination.
Step Phase Temperature (◦C) Time Cycle numbers
1 Initial Denaturation 95 10min 1
2 Denaturation 95 10 s 40
3 Annealing 60 5 s
4 Elongation 72 20 s
5 Final elongation 72 5min 1
TABLE 4 | Primer sequences for quantitative real-time PCR and standard
preparation.
Primer for amplification of standard
fragment
Sequence (5′ to 3′)
WPREqF AGTTCCGCCGTGGCAATAGG
WPREqR CAAGGAGGAGAAAATGAAAGCC
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FIGURE 2 | OS preparation and FRET. (A) Overview of the protocol for the OS preparation and for the subsequent FRET measurements. (B) Representative
images of isolated OS at different time points after the isolation. Scale bar, 3µm.
to ensure a sufficient number of fluorescent OS. The OS were
separated from the retina by vortexing for 15–30 s. Vortexing
should not surpass 30 s as excessive shearing disrupts the
shape of OS. Afterwards, centrifugation was conducted at 500
× g for 30 s and the supernatant was carefully transferred
to a fresh 1.5-ml-microcentrifuge-tube without disturbing the
pellet. The supernatant contained the OS fraction suitable for
FRET measurements. If desirable, the quality and fluorescence
of purified OS can be analyzed (Figure 2B) on a standard
epifluorescence or confocal microscope by transferring 5–10µl
of supernatant on microscope slides topped with cover slips.
FRET Measurements on Isolated Outer
Segments
Setup of FRET Microscope, Software, and OS Sample
Calculation of three cube sensitized acceptor emission FRET
requires data for FRET donor (cerulean) only and acceptor
(citrine) only samples (Erickson et al., 2003; Shaltiel et al., 2012;
Ben Johny et al., 2013). Therefore, in addition to the fluorescence
signals from OS co-expressing cerulean and citrine constructs,
OS expressing cerulean- or citrine-tagged proteins only must be
imaged as well. For optimized signal acquisition, we recommend
to start the FRET measurements with OS co-expressing both
cerulean- and citrine-tagged FRET partners (hereinafter referred
to as FRET sample).
Purified OS solution was diluted in 400µl FRET imaging
solution and was transferred to the center of an imaging
dish. FRET measurements should be performed on single
OS as fluorescence from adjacent OS might interfere with
the measurements. Therefore, the density of OS should be
adjusted in order to allow for detection of single fluorescent
OS within the defined region of interest on the imaging setup
(image-plane pinhole). As the density of transduced OS varies
with transduction and purification efficiency, it is necessary to
individually adjust the amount of OS for each preparation. The
OS were allowed to sediment to the bottom for 10–15min at
room temperature. The fluorescence lamp was turned on at least
30min prior to the experiment to ensure stable illumination.
The image-plane pinhole was set to an appropriate size that
allows monitoring of a single OS, which was positioned in the
center of the axial beam path. This position must not be changed
throughout the entire FRET measurements performed on the
same day. The FelixGX software was started to acquire the
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fluorescence intensities. An oil-immersion and high-resolution
objective (40x or higher) was used and immersion medium was
applied. The imaging dish was placed onto the sample holder
and bright field illumination was used to focus on OS. Individual
OS were identified based on their characteristic morphology as
shown in Figure 2B.
Measurements on the FRET Sample
For measurements of FRET samples, OS that express sufficient
levels of both citrine and cerulean were used. A fluorescent OS
was placed in the center of the optic field and fluorescence from
adjacent cells invading the optic field was excluded. Gain and
fluorescence intensity settings were adjusted in order to achieve
an appropriate signal prior to the first signal acquisition. All
subsequent data must be acquired under the same conditions.
Fluorescence intensities were collected with the cerulean cube,
FRET cube, and citrine cube. The settings for the single cubes are
as follows:
For cerulean cube: 426–446 nm excitation filter, T455lp
dichroic mirror, and 460–500 nm emission filter; for citrine cube:
490–510 nm excitation filter, T515lp dichroic mirror, and 510–
550 nm emission filter; for FRET cube: 426–446 nm excitation
filter, T455lp dichroic mirror, and 510–550 nm emission filter.
The data for a single OS was acquired according to the
following sequence: cerulean excitation was started and the
signals with the cerulean cube followed by the FRET cube were
obtained. Then, citrine excitation was carried out and the signal
with the citrine cube was obtained. 25–35 individual OS were
measured. To subtract the OS autofluorescence, the same three
cube protocol as described above was applied to ∼10 OS that do
not express citrine or cerulean within the corresponding sample.
Cerulean-only Expressing Preparation
OS with varying expression levels of cerulean were used. For each
OS, the fluorescence intensity was measured with the cerulean,
FRET, and citrine filter cube according to the same protocol as
described above for the FRET sample. Data from at least 15 OS
were collected. To subtract the OS autofluorescence, the cerulean,
FRET, and citrine cube were measured for ∼10 OS that do not
express cerulean within the same sample.
Citrine-only Expressing Preparation
OSwith varying expression levels of citrine were chosen. For each
OS, the fluorescence intensity was measured with the cerulean,
FRET, and citrine filter cube according to the same protocol as
described above for the FRET sample. Data from at least 15 OS
were collected. To subtract the OS autofluorescence, the cerulean,
FRET, and citrine cube were measured for ∼10 OS that do not
express citrine within the same sample.
Data Analysis
The data set consists of three data points per OS, i.e., one
intensity value for each filter cube. As controls, we additionally
included data points measured from non-fluorescent OS for
background subtraction as well as from cerulean-only and
citrine-only expressing OS for donor bleed-through and cross-
excitation corrections, respectively. The data was transferred to
an Excel sheet or an adequate data processing program. For the
10 non-fluorescent OS measured for each of the preparations,
i.e. FRET, cerulean-only and citrine-only, the mean intensity
values were calculated. These mean values were subtracted from
each data point of the particular preparation to adjust for
background fluorescence. In order to correct for donor bleed-
through, the correction constant RD1 for each of the single data
points gathered from the cerulean-only expressing preparation
was calculated by dividing the intensities captured with the
FRET-cube by those obtained from the cerulean-cube. In order
to correct for acceptor cross-excitation, the correction constant
RA for each single data point gathered from the citrine-only
expressing preparation was calculated by dividing the intensities
captured with the FRET-cube by those obtained from the
citrine-cube. The mean value for both constants, RD1 and RA,
was calculated. Usually, a value of ∼0.25 for cerulean (donor-
bleed through) and 0.03 for citrine (acceptor cross-excitation)
was obtained in our setup. However, these values might differ
with fluorophore variant, protein tag, and imaging setup. The
calculated constants were used for donor bleed-through and
acceptor cross-excitation to evaluate the FRET ratio (FR) for each
single measurement according to the following equation:
FR =
SFRET − RD1 · Scerulean
RA · Scitrine
Scerulean, Scitrine, and SFRET are intensity signals acquired with
respective filter cubes (FRET, cerulean, and citrine) in a
FRET specimen and RA, RD1 are predetermined factors for
calibration issues (RA: Acceptor cross-excitation, RD1: Donor
bleed-through). Depending on the imaging setup and, in
particular, the filter set used for experiments, a considerable
amount of cerulean fluorescence may be detected by the citrine
cube. To correct for this, an additional donor bleed-trough
correction constant RD2 should be calculated by dividing the
cerulean fluorescence intensity obtained with the citrine cube by
the one detected with the cerulean cube. Accordingly, the FR
equation was adjusted to: (Erickson et al., 2003)
FR =
SFRET − RD1 · Scerulean
RA · (Scitrine − RD2 · Scerulean)
In our FRET setup, RD2 was negligibly small and could thus
be ignored. However, it should be rigorously tested for each
individual imaging setup. The mean value of the previously
obtained data was calculated. The mean value represents
the overall FR. Note that the FR values are instrumentation
dependent. FRET efficiencies (EA) (which are independent of
the setup used) can be easily calculated from the FR using the
following equation:
EA = [FR− 1] ·
εcitrine(436)
εcerulean(436)
εcitrine and εcerulean are the FRET setup specific average molar
extinction coefficients for citrine and cerulean, respectively.
Troubleshooting
Problems, possible underlying reasons and advices concerning
critical steps of the procedure can be found in Table 5.
Frontiers in Neuroscience | www.frontiersin.org 9 July 2016 | Volume 10 | Article 356
Becirovic et al. AAVs for FRET in Photoreceptors
TABLE 5 | Troubleshooting.
Problem Possible Reason Solution
Low titer. Transfection reagents do not have sufficient transfection
efficiency.
Test transfection reagents for their efficiencies.
Requantify plasmid concentration used for transfection.
pH of HEK293T cell medium is not optimal for transfection. Remove HEK293T dishes from incubator immediately
before transfection.
The sequence of the ITRs (inverted terminal repeats) within
the plasmid is not intact, thus replication and packaging of
the rAAV vector is inefficient.
Check for the presence of SmaI and/or Eam1105I
restriction sites within the palindromic ITR sequence. In
case of unexpected restriction fragment band pattern,
repeat cloning using an intact rAAV vector.
The injection bleb in the subretinal
space is not visible under the
surgical/stereomicroscope.
The eye shows damages or opacity of the cornea. Make sure to choose only mice with clear, intact eyes for
subretinal injection. Check the eyes under the
stereomicroscope.
Virus suspensions diluted with double-distilled water to
adjust the particle concentration do not show optical
refraction as clear as the virus suspension in 0.014%
Tween/PBS-MK.
Dilute with 0.014% Tween/PBS-MK to adjust virus
particle concentration. If the suspension is too viscous,
dilute with double-distilled water at a maximum ratio of
1:2 (water-to-virus suspension).
The injection angle is not optimal. Adjust the injection angle to ∼60◦.
Loss of many OS. Removal of the pigment epithelium and ciliary body after
retina isolation with foreceps may result in loss of many OS.
Proceed with the next step without any removal of
undesirable tissue.
Protein expression level is too low, thus
leading to a too weak or absent
fluorescence signal.
Virus suspension is not (completely) injected into the
subretinal space.
Make sure to see a clear injection bleb as this indicates
the correct injection to the subretinal space. An injection
into the upper layers of the eye such as sclera or
choroidea causes a bleb outside at the globe. If the
needle is intravitreal, it can be clearly and sharply seen
under the stereomicroscope. By contrast, a needle in the
subretinal space (injection angle at ∼60◦) appears rather
blurred. Keep the injection needle for at least 20 s in the
bleb to ensure proper delivery of the desired volume. If
possible, perform OCT measurements on the
anesthetized mouse after injection to confirm
detachment of the retina at the injection position.
Virus titer has not been determined correctly. Double check the virus titer. Otherwise, repeat the virus
production.
Time Schedule
• Transfection of HEK293T cells: 48 h
• Isolation of rAAV: 2–4 h (varies depending on number of
dishes to be harvested)
• Gradient purification and rAAV concentration: 6 h (for 2
different rAAV constructs)
• Titer determination via quantitative real-time PCR: 2 h
• Preparation of standards for titer determination: 2 h
• Subretinal injection: 20min (per mouse)
• rAAV transduction of murine retina and protein expression:
10 days
• Isolation of photoreceptor OS: 10min (per eye)
• FRET imaging: 5–9 h (depending on number of retinas to be
analyzed)
• Data analysis: 2–3 h (depending on number of measurements
to be processed).
ANTICIPATED RESULTS AND DISCUSSION
In this protocol, we demonstrate that robust FRET signals
can be measured for well-known homomeric and heteromeric
interactions of different membrane and soluble proteins in OS
of rod and cone photoreceptors. Representative results are found
in our previous publications (Becirovic et al., 2014; Nguyen
et al., 2016). Selected data from these publications are presented
in the modified graphs shown in Figure 3. FRET is given as
FRET efficiencies (EA) which can be easily calculated from the
FRET ratios (FR) as shown in the “Data Analysis” Section. It
is noteworthy to mention that the mean value of EA may not
represent the maximal FRET efficiency (EA max). EA max can be
calculated if a relatively high variability of the cerulean/citrine
molar ratios is present in FRET measurements. If this is the case,
single FRET values can be plotted against the cerulean/citrine
intensity ratios to obtain the binding curves and to calculate
EA max. A comparison of EA max between different constructs
allows for the determination of relative binding affinities. Since
EA max is directly proportional to the binding affinity, ourmethod
in principle should also allow for comparisons of relative binding
affinities of single protein-protein interactions in an isolated
subcellular compartment.
Taken together, our protocol enables the measurement of
robust FRET signals ex vivo in small and highly specialized
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FIGURE 3 | FRET measurements in isolated photoreceptor OS. (A) Schematic depiction of the single constructs used for the subretinal injection and for the
determination of the FRET efficiencies (EA) shown in (C). (B) Representative confocal images of single isolated rod OS co-expressing C-terminally tagged peripherin-2
and rhodopsin. The excitation wavelength and emission filter settings used to obtain the single channels (Donor, FRET and Acceptor) are summarized in the “Stepwise
Procedures” section. Scale bar, 1.5µm. (C) Results of the FRET measurements for different FRET pair combinations given as mean values ± standard error of the
mean (SEM). Numbers of independent measurements (n) are given in brackets. EA values for the single FRET pairs are as follows: Rho-Rho, EA = 10.45 ± 0.78;
Rho-citr-P, EA = 4.52 ± 0.82; Rho-P-citr, EA = 2.76 ± 0.65; Rho-GARP2, EA = 0.26 ± 0.65; (D) Schematic view of the single constructs used for the subretinal
injection and for the determination of the FRET efficiencies (EA) shown in (F). (E) Representative confocal images of single isolated cone OS co-expressing C-terminally
tagged peripherin-2 and cone opsin. Scale bar, 1.5µm. (F) Results of the FRET measurements (given as mean values ± SEM) for different FRET pair combinations as
indicated. Numbers of independent measurements (n) are given in brackets. EA values for the single FRET pairs are described elsewhere (Nguyen et al., 2016).
cellular compartments of mammalian cells like OS of murine
photoreceptors. This allows for the systematic analysis of protein-
protein interactions in a physiological or pathophysiological
context of the photoreceptor biology. In particular, it can be used
to analyze the effects of disease-associated mutations on protein-
protein interactions. OS of photoreceptors are modified cilia.
Ciliopathies encompass a very large group of genetic disorders
compromising the functional or structural integrity of cilia.
Since the isolation of ciliary compartments from other tissues
(i.e. kidney, lung, brain, olfactory epithelium) is well-established
(Mitchell et al., 2009), our protocol should also be transferable
to analyses of protein-protein interactions in any other ciliated
tissue. In non-dividing cells, rAAVs lead to an episomal and
long-term expression of the respective gene for up to several
years (Trapani et al., 2014). Thus, FRET measurements can be
performed on several time points during the development of the
tissue. Finally, our protocol could also provide an experimental
basis for the establishment of FRET measurements in the retina
of living animals by means of fundus ophthalmoscopy combined
with e.g., conventional fluorescence imaging, 2-photon imaging,
multiphoton FLIM-FRET, or near infrared-FRET fluorescence
lifetime imaging (Abe et al., 2013; Johnsson et al., 2014).
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